SCHEMBL5070942

SCHEMBL5070942

CN(C)c1nc2ccc(Oc3ccc4c(O)c(C(=O)NC(C(=O)O)C(NC(=O)c5ncc6cc(SC7CCCC7)ccc6c5O)C(=O)O)ncc4c3)cc2s1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 17/20 0.42
EGLN1 Q9GZT9 14/20 0.42
CSF1R P07333 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5070941 0.89 EGLN1 (0.53) EGLN2EGLN1CSF1R
SCHEMBL3782146 0.77 EGLN1 (0.66) EGLN2EGLN1
SCHEMBL3779142 0.68 EGLN1 (0.57) EGLN2EGLN1
SCHEMBL3779443 0.67 TDP1 (0.55) EGLN2EGLN1
SCHEMBL30274573 0.67 EGLN1 (0.56) EGLN2EGLN1
SCHEMBL522188 0.67 EGLN1 (0.56) EGLN2EGLN1
SCHEMBL2140310 0.67 ABL1 (0.50) EGLN2EGLN1
SCHEMBL523046 0.67 EGLN2 (0.49) EGLN2EGLN1
SCHEMBL523047 0.67 EGLN2 (0.49) EGLN2EGLN1
SCHEMBL1219877 0.66 EGLN1 (0.69) EGLN2EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893186-A2 IMPROVED TREATMENT FOR ANEMIA USING A HIF-ALPHA STABILISING AGENT FIBROGEN, INC. (US) 2008-03-05 EP disclosed
WO-2006133391-A2 IMPROVED TREATMENT FOR ANEMIA USING A HIF-ALPHA STABILISING AGENT FIBROGEN, INC. (US) 2006-12-14 WO disclosed